mitoxantrone has been researched along with Myotonic Dystrophy in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashem, VI | 1 |
| Pytlos, MJ | 1 |
| Klysik, EA | 1 |
| Tsuji, K | 1 |
| Khajavi, M | 1 |
| Khajav, M | 1 |
| Ashizawa, T | 1 |
| Sinden, RR | 1 |
1 other study available for mitoxantrone and Myotonic Dystrophy
| Article | Year |
|---|---|
Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients.
Topics: Alleles; Antineoplastic Agents, Alkylating; Cell Line; Doxorubicin; Ethyl Methanesulfonate; Humans; | 2004 |